Indian drugmaker Cipla beats profit view on steady respiratory drugs demand

India's Cipla reported a better-than-expected second-quarter profit on Thursday, driven by steady demand for its respiratory ...

Indian drugmaker Cipla beats profit view on steady demand for respiratory drugs

India's Cipla reported a better-than-expected second-quarter profit on Thursday, driven by steady demand for its respiratory ...

Asia stocks sink on caution over Trump-Xi deal, BOJ hold hits yen

SINGAPORE (Reuters) -Asian stocks veered between gains and losses on Thursday after U. President Donald Trump said he had ...

Stellantis posts higher revenues, trims estimates on U.S. tariff impact

MILAN (Reuters) -Automaker Stellantis on Thursday reported a 13% year-on-year increase in revenues for the third quarter, ...
LIVE

Stock market today: Dow, S&P 500, Nasdaq futures hit pause after Trump-Xi meeting, Big Tech earnings

Wall Street digested President Trump's long-awaited summit with Chinese leader Xi Jinping, a wave of Big Tech earnings, and the Fed's latest policy meeting.